Musk's Neuralink says FDA has approved human trials
Elon Musk's brain-implant company Neuralink said on Thursday it had been given a green light from the U.S. FDA to kickstart its first-in-human clinical study. It's a critical milestone for Neuralink after earlier struggles to gain approval.
